Glempa 25mg Tablet

Glempa 25mg Tablet contains the active ingredient empagliflozin, which belongs to the class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is prescribed for the treatment of type 2 diabetes mellitus.

Active Ingredient:

• Empagliflozin: Works by inhibiting the reabsorption of glucose in the kidneys, leading to increased urinary excretion of glucose and thus lowering blood sugar levels.

Uses:

Glempa 25mg Tablet is indicated for the management of type 2 diabetes mellitus in adults. It helps control blood sugar levels by promoting the excretion of glucose in the urine.

Mechanism of Action:

Empagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which is responsible for the reabsorption of glucose into the bloodstream. By blocking this transporter, empagliflozin prevents the reabsorption of glucose, allowing it to be excreted in the urine. This results in a reduction of blood glucose levels.

Administration:

Glempa 25mg Tablet is typically taken orally, once daily, with or without food. The dosage may vary depending on individual response and other factors. Patients should follow the dosage instructions provided by their healthcare provider.

Side Effects:

Common side effects of Glempa 25mg Tablet may include:

• Genital yeast infections
• Urinary tract infections
• Increased urination
• Thirst
• Nausea
• Diarrhea
• Hypoglycemia (low blood sugar)

Precautions:

Before using Glempa 25mg Tablet, patients should consider the following precautions:

• Inform healthcare providers of any known allergies to empagliflozin or other medications.
• Monitor blood sugar levels regularly, especially during initial treatment or dosage adjustments.
• Use caution in patients with kidney problems or dehydration.
• Avoid excessive alcohol consumption, as it may increase the risk of hypoglycemia.
• Inform healthcare providers of any other medications, supplements, or herbal products being taken, as they may interact with empagliflozin.